27 October 2026
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Mark Roeder Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| John Williams Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Caitlin Nguyen | Latham & Watkins LLP | Associate | corporate | Not stated |
| Tony Noh | Latham & Watkins LLP | Associate | corporate | Not stated |
| Taleah Tyrell | Latham & Watkins LLP | Associate | corporate | Not stated |
| Robert Yeh | Latham & Watkins LLP | Counsel | intellectual property | San Diego |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Washington, D.C. |
| Evan Rothkoff | Latham & Watkins LLP | Associate | regulatory | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Francis Shih | Latham & Watkins LLP | Not stated | tax | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 250m (US$250 million)
- What the figure measures
- Issue size
- Client
- Arcus Biosciences, Inc.Issuer
- Counterparties
- Not stated